Serum anti-cyclic citrullinated peptide antibodies may predict disease activity in rheumatoid arthritis
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Serum anti-cyclic citrullinated peptide antibodies may predict disease activity in rheumatoid arthritis
Authors
Keywords
-
Journal
RHEUMATOLOGY INTERNATIONAL
Volume 32, Issue 12, Pages 3799-3805
Publisher
Springer Nature
Online
2011-12-20
DOI
10.1007/s00296-011-2282-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Serum adenosine deaminase may predict disease activity in rheumatoid arthritis
- (2011) Batool Zamani et al. RHEUMATOLOGY INTERNATIONAL
- Increased myeloperoxidase plasma levels in rheumatoid arthritis
- (2011) Raissa Maria Sampaio Neves Fernandes et al. RHEUMATOLOGY INTERNATIONAL
- Relationship between serum acute-phase proteins and high disease activity in patients with rheumatoid arthritis
- (2010) B Cylwik et al. Advances in Medical Sciences
- Anti-CCP antibody and rheumatoid factor concentrations predict greater disease activity in men with rheumatoid arthritis
- (2010) B. J. Miriovsky et al. ANNALS OF THE RHEUMATIC DISEASES
- The continuous measurement of anti-CCP-antibodies does not help to evaluate the disease activity in anti-CCP-antibody-positive patients with rheumatoid arthritis
- (2010) Thoren Landmann et al. CLINICAL RHEUMATOLOGY
- Factors Associated with Radiographic Progression in Patients with Rheumatoid Arthritis Who Were Treated with Methotrexate
- (2010) M. E. WEINBLATT et al. JOURNAL OF RHEUMATOLOGY
- Prognostic Factors of Radiological Damage in Rheumatoid Arthritis: A 10-year Retrospective Study
- (2010) T. E. MARKATSELI et al. JOURNAL OF RHEUMATOLOGY
- Assessment of the validity of the 28-joint disease activity score using erythrocyte sedimentation rate (DAS28-ESR) as a disease activity index of rheumatoid arthritis in the efficacy evaluation of 24-week treatment with tocilizumab: subanalysis of the SATORI study
- (2010) Norihiro Nishimoto et al. Modern Rheumatology
- Antibodies against cyclic citrullinated peptide don’t decrease after 6 months of infliximab treatment in refractory rheumatoid arthritis
- (2010) Bogdan Kolarz et al. RHEUMATOLOGY INTERNATIONAL
- Synovial fluid adenosine deaminase and high-sensitivity C-reactive protein activity in differentiating monoarthritis
- (2010) Batool Zamani et al. RHEUMATOLOGY INTERNATIONAL
- Anti-cyclic citrullinated peptide antibody predicts functional disability in patients with rheumatoid arthritis in a large prospective observational cohort in Japan
- (2010) Kumi Shidara et al. RHEUMATOLOGY INTERNATIONAL
- Plasma soluble IL-6 receptor concentration in rheumatoid arthritis: associations with the rs8192284 IL6R polymorphism and with disease activity
- (2010) Luis Rodríguez-Rodríguez et al. RHEUMATOLOGY INTERNATIONAL
- Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis
- (2009) Michael P. M. van der Linden et al. ARTHRITIS AND RHEUMATISM
- The prevalence of musculoskeletal complaints in a rural area in Iran: a WHO-ILAR COPCORD study (stage 1, rural study) in Iran
- (2009) Fereydoun Davatchi et al. CLINICAL RHEUMATOLOGY
- Serum levels of anti-cyclic citrullinated peptide antibodies are associated with a beneficial response to traditional herbal medicine (Kampo) in rheumatoid arthritis
- (2009) Toshiaki Kogure et al. RHEUMATOLOGY INTERNATIONAL
- Antibody against mutated citrullinated vimentin: a new sensitive marker in the diagnosis of rheumatoid arthritis
- (2009) Ernst Wagner et al. RHEUMATOLOGY INTERNATIONAL
- Third generation anti-cyclic citrullinated peptide antibodies do not predict anti-TNF-α treatment response in rheumatoid arthritis
- (2009) Christian Dejaco et al. RHEUMATOLOGY INTERNATIONAL
- The diagnostic utilities of anti-agalactosyl IgG antibodies, anti-cyclic citrullinated peptide antibodies, and rheumatoid factors in rheumatoid arthritis
- (2009) Hee Jung Ryu et al. RHEUMATOLOGY INTERNATIONAL
- Association of anti-CCP positivity with serum ferritin and DAS-28
- (2009) Burcu Önder et al. RHEUMATOLOGY INTERNATIONAL
- Are anti-citrulline autoantibodies better serum markers for rheumatoid arthritis than rheumatoid factor in Thai population?
- (2009) Monchand Vanichapuntu et al. RHEUMATOLOGY INTERNATIONAL
- The association of anti-CCP antibodies with disease activity in rheumatoid arthritis
- (2008) Münevver Serdaroğlu et al. RHEUMATOLOGY INTERNATIONAL
- Assessment of adenosine deaminase levels in rheumatoid arthritis patients receiving anti-TNF-α therapy
- (2008) Burak Erer et al. RHEUMATOLOGY INTERNATIONAL
- Anti‐CCP2 is an adjunct to, not a surrogate for, rheumatoid factor in the diagnosis of rheumatoid arthritis: diagnostic utility of anti‐CCP2 antibodies in Egyptian patients with rheumatoid arthritis
- (2008) A. M. Abdel‐Nasser et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started